Roles of host mitochondria in the development of COVID-19 pathology: Could mitochondria be a potential therapeutic target?

Abstract The recent emergence of severe acute respiratory syndrome-Corona Virus 2 (SARS-CoV-2) in late 2019 and its spread worldwide caused an acute pandemic of Coronavirus disease 19 (COVID-19). Since then, COVID-19 has been under intense scrutiny as its outbreak led to significant changes in healt...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kavya Srinivasan, Ashutosh Kumar Pandey, Ashlena Livingston, Sundararajan Venkatesh
Formato: article
Lenguaje:EN
Publicado: Springer 2021
Materias:
R
Acceso en línea:https://doaj.org/article/eb8ae861dd8748d38f8c1dbfddd6fde6
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:eb8ae861dd8748d38f8c1dbfddd6fde6
record_format dspace
spelling oai:doaj.org-article:eb8ae861dd8748d38f8c1dbfddd6fde62021-11-28T12:04:57ZRoles of host mitochondria in the development of COVID-19 pathology: Could mitochondria be a potential therapeutic target?10.1186/s43556-021-00060-12662-8651https://doaj.org/article/eb8ae861dd8748d38f8c1dbfddd6fde62021-11-01T00:00:00Zhttps://doi.org/10.1186/s43556-021-00060-1https://doaj.org/toc/2662-8651Abstract The recent emergence of severe acute respiratory syndrome-Corona Virus 2 (SARS-CoV-2) in late 2019 and its spread worldwide caused an acute pandemic of Coronavirus disease 19 (COVID-19). Since then, COVID-19 has been under intense scrutiny as its outbreak led to significant changes in healthcare, social activities, and economic settings worldwide. Although angiotensin-converting enzyme-2 (ACE-2) receptor is shown to be the primary port of SARS-CoV-2 entry in cells, the mechanisms behind the establishment and pathologies of COVID-19 are poorly understood. As recent studies have shown that host mitochondria play an essential role in virus-mediated innate immune response, pathologies, and infection, in this review, we will discuss in detail the entry and progression of SARS-CoV-2 and how mitochondria could play roles in COVID-19 disease. We will also review the potential interactions between SARS-CoV-2 and mitochondria and discuss possible treatments, including whether mitochondria as a potential therapeutic target in COVID-19. Understanding SARS-CoV-2 and mitochondrial interactions mediated virus establishment, inflammation, and other consequences may provide a unique mechanism and conceptual advancement in finding a novel treatment for COVID-19.Kavya SrinivasanAshutosh Kumar PandeyAshlena LivingstonSundararajan VenkateshSpringerarticleCOVID-19SARS-CoV-2MitochondriaACE-2 receptorCytokine stormInflammationMedicineRENMolecular Biomedicine, Vol 2, Iss 1, Pp 1-19 (2021)
institution DOAJ
collection DOAJ
language EN
topic COVID-19
SARS-CoV-2
Mitochondria
ACE-2 receptor
Cytokine storm
Inflammation
Medicine
R
spellingShingle COVID-19
SARS-CoV-2
Mitochondria
ACE-2 receptor
Cytokine storm
Inflammation
Medicine
R
Kavya Srinivasan
Ashutosh Kumar Pandey
Ashlena Livingston
Sundararajan Venkatesh
Roles of host mitochondria in the development of COVID-19 pathology: Could mitochondria be a potential therapeutic target?
description Abstract The recent emergence of severe acute respiratory syndrome-Corona Virus 2 (SARS-CoV-2) in late 2019 and its spread worldwide caused an acute pandemic of Coronavirus disease 19 (COVID-19). Since then, COVID-19 has been under intense scrutiny as its outbreak led to significant changes in healthcare, social activities, and economic settings worldwide. Although angiotensin-converting enzyme-2 (ACE-2) receptor is shown to be the primary port of SARS-CoV-2 entry in cells, the mechanisms behind the establishment and pathologies of COVID-19 are poorly understood. As recent studies have shown that host mitochondria play an essential role in virus-mediated innate immune response, pathologies, and infection, in this review, we will discuss in detail the entry and progression of SARS-CoV-2 and how mitochondria could play roles in COVID-19 disease. We will also review the potential interactions between SARS-CoV-2 and mitochondria and discuss possible treatments, including whether mitochondria as a potential therapeutic target in COVID-19. Understanding SARS-CoV-2 and mitochondrial interactions mediated virus establishment, inflammation, and other consequences may provide a unique mechanism and conceptual advancement in finding a novel treatment for COVID-19.
format article
author Kavya Srinivasan
Ashutosh Kumar Pandey
Ashlena Livingston
Sundararajan Venkatesh
author_facet Kavya Srinivasan
Ashutosh Kumar Pandey
Ashlena Livingston
Sundararajan Venkatesh
author_sort Kavya Srinivasan
title Roles of host mitochondria in the development of COVID-19 pathology: Could mitochondria be a potential therapeutic target?
title_short Roles of host mitochondria in the development of COVID-19 pathology: Could mitochondria be a potential therapeutic target?
title_full Roles of host mitochondria in the development of COVID-19 pathology: Could mitochondria be a potential therapeutic target?
title_fullStr Roles of host mitochondria in the development of COVID-19 pathology: Could mitochondria be a potential therapeutic target?
title_full_unstemmed Roles of host mitochondria in the development of COVID-19 pathology: Could mitochondria be a potential therapeutic target?
title_sort roles of host mitochondria in the development of covid-19 pathology: could mitochondria be a potential therapeutic target?
publisher Springer
publishDate 2021
url https://doaj.org/article/eb8ae861dd8748d38f8c1dbfddd6fde6
work_keys_str_mv AT kavyasrinivasan rolesofhostmitochondriainthedevelopmentofcovid19pathologycouldmitochondriabeapotentialtherapeutictarget
AT ashutoshkumarpandey rolesofhostmitochondriainthedevelopmentofcovid19pathologycouldmitochondriabeapotentialtherapeutictarget
AT ashlenalivingston rolesofhostmitochondriainthedevelopmentofcovid19pathologycouldmitochondriabeapotentialtherapeutictarget
AT sundararajanvenkatesh rolesofhostmitochondriainthedevelopmentofcovid19pathologycouldmitochondriabeapotentialtherapeutictarget
_version_ 1718408232248016896